MedTech Dive October 22, 2024
The conference — Advamed’s largest — featured an appearance by the device center’s new acting director and sessions on AI, clinical trial diversity and the FDA’s contentious LDT rule.
Thousands of medical device professionals gathered last week at The Medtech Conference in Toronto to discuss upcoming policies, new technologies and medtech trends.
The event, Advamed’s largest to date, brought 4,350 attendees from 48 countries, and featured comments from Michelle Tarver, who was recently named acting director of the Food and Drug Administration’s device center. Other FDA leaders also spoke last week, as did regulators from Canada, Europe and Japan.
Discussions about artificial intelligence and machine learning, upcoming deadlines for the FDA’s laboratory developed test rule, diversity and patient representation, and...
Today's Sponsors
Today's Sponsor